| Application no. and date | 09797234.3 (espacenet) (Federated) (European Patent Register), 20091221 | | Patent/reg. no. and date | DK/EP 2379067, 20150902 | | Publication date | 20111026 | | Priority no. and date | US 139672 P, 20081222, US 218530 P, 20090619, US 246715 P, 20090929 | | EP pub. no. and date |
EP 2379067 20111026 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | T5063DK00 | | Inventor | SCHMOUDER, Robert, Novartis
One Health Plaza
East Hanover
NJ 07936, US,
DUMORTIER, Thomas, Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
DAVID, Olivier, Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
LOOBY, Michael, Novartis Pharma AG
Postfach
CH-4002 Basel, CH | | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | | Opponent | | | IPC Class | A61K 31/135 (2006.01) , A61K 31/137 (2006.01) , A61K 31/138 (2006.01) , A61K 31/661 (2006.01) , A61P 37/00 (2006.01) , A61P 37/06 (2006.01) , C07F 9/10 (2006.01) | | Title | DOSERINGSREGIMEN FOR FINGOLIMOD TIL BEHANDLING AF MULTIPEL SKLEROSE | | Int. application no. | US2009068888 | | Int. publication no. | WO2010075239 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
